We also assessed LVH with activity changes of ventricular myosin light chain 2 (MLC2v) and Rho-associated kinase 1/2 (ROCK 1/2), two well-established markers of cardiac hypertrophy [17, 18]. The gene discussed is MYL2; the disease is cardiac hypertrophy.